Promising disease modifying approach to Duchenne muscular dystrophy with Neu-REFIX® Beta 1,3-1,6 glucan* from Japan; the first such clinical report.

TOKYO--(BUSINESS WIRE)--Aug 4, 2023--

Related Keywords

Japan ,United States ,Texas ,Japanese ,Naoki Yamamoto ,Samuel Jk Abraham ,Aureobasidium Pullulans ,International Holding Group ,Gn Corporation Co Ltd ,Muscular Dystrophy ,Business Wire ,Holding Group ,Limb Girdle Muscle Dystrophy ,